Werewolf Therapeutics (HOWL) Beats Q2 Earnings Estimates by $0.39
Earnings Results Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly earnings results on July 31, 2026 that exceeded analyst expectations. The Healthcare company reported…
Read more
